NeuroQure Acquires Patents to Detect Autism in Newborns with a Skin Sample
The company has acquired the exclusive rights to license a patent portfolio from the UC Irvine Center for Autism Research and Translation (CART).
- The company has acquired the exclusive rights to license a patent portfolio from the UC Irvine Center for Autism Research and Translation (CART).
- Ph.D. and his team during his tenure as Founding Director of CART.
- In securing the exclusive license of UC Irvine's CART patents, NeuroQure is poised to revolutionize the landscape of Autism diagnostics.
- The company's dedication to addressing the gap in current technologies underscores its commitment to transform the lives of children and families affected by ASD.